Industry

Translating Cell and Gene Therapy: Interviews with Dr. Bo Kara and Dr. Jacqueline Barry

Ahead of the SIULondon ‘Advances in Immunotherapy’ event, we interviewed Dr. Bo Kara from GlaxoSmithKline (GSK) and Dr. Jacqueline Barry from Cell and Gene Therapy (CGT) Catapult. Both experts share their role in supporting the cell and gene therapy field and give their insights on industry science and more… Read on here.

SIUConversations Frankfurt: Academic Breakout- Alternative Careers in Biotech

On January 25th, 2018 SIU Frankfurt hosted a highly attended event on alternative careers in big pharma and biotech. Dr. Jens Atzrodt, Karin Messer and Dr. José Airas were our guest speakers, who have leading roles in R&D, Human Resources and Consultancy at Sanofi Germany and Merck respectively. Read on for their advice to early career scientists open to pursuing careers in industry...

SIUConversations Oxford: Academia And Industry - Advancing Science And Your Career

SIUOxford hosted our first educational event for this academic year on November 16th 2017, titled ‘Academia and Industry: Advancing Science and Your Career’. We welcomed three professionals, all with experience in both academia and industry, to share their career journeys and to offer advice to attendees on how to approach bridging the gap between the two areas.

Brexit: The Divorce Battle over Life Sciences and Funding

On June 23, 2016, the United Kingdom voted to leave the European Union in what could either be described as a catastrophic self-destruction or a glorious grasp at independence. Wrapped up in a state of confusion over their status in the United Kingdom are scientists from Europe and abroad. On June 8, 2017, almost one year after the referendum, SIU brought together experts in London, to talk about their concerns and current measures they are taking in academia, industry and government to make things as smooth as possible for UK science. 

Academic-Industrial Collaboration: How To Make It Work

Progress in modern scientific research is accomplished primarily by collaborative teamwork. In this piece that got shortlisted for the SIU-Naturejobs writing competition, University of Oxford PhD student Sofia D'Abrantes discusses the advantages of academic-industrial collaborations, her advice to foment successful partnerships and what you can do to encourage them.

Inspiring Innovation: Bringing Academia And Industry Together at the Royal Society

Did you know that there is much more to the Royal Society than being the world's oldest academy and a fellowship of prestigious scientists? In the second session of SIUConversations in Oxford on March 1st, our audience found out about the projects the Royal Society holds to inspire and initiate innovation in the UK. Read on to find out more.

The Call for Cheaper Drug Development

Drug development is a very lengthy and expensive process. Are there ways to make the process easier and cheaper? Here we discuss the current trends in the pharma industry, if these trends are enough to achieve what's in the best interest of the industry, scientists, and most importantly, the patients, and what can be done to improve the situation in the future.

SIU360 Oxford Session 1: Opportunity Recognition and Construction

The first Oxford session of the SIU360 educational series took place on October 18th, at the Saïd Business School, University of Oxford. Our speaker was Prof. Chas Bountra. The talk drew a large group of attendees, who were inspired by Prof. Bountra's engaging talk on open sourcing in translational research. 

BREXIT vs. SCIENCE Part 3: Brexit and Biotech

What awaits the biotech industry in the UK post-Brexit? Can the UK continue to thrive in biotech after the break-up from the EU is finalised? In the last instalment of our 'Brexit vs. Science' series we discuss the facts and speculations surrounding the most obvious questions on the effects of Brexit on the UK biotech industry.